Results of Outcome Measures in Rheumatology Clinical Trials (OMERACT) voting on domains to be included in clinical trials in psoriatic arthritis
No | Item | Score |
---|---|---|
1 | Joint activity | 99% |
2 | Patient global | 96% |
All three components (total, joints, skin) | 76% | |
3 | Pain assessment | 94% |
4 | Physical function | 91% |
5 | Skin disease | 86% |
6 | Quality of life | 78% |
7 | Structural damage | 66% |
8 | Acute phase reactant | 64% |
9 | Axial involvement | 61% |
10 | Participation | 61% |
11 | Enthesitis | 60% |
12 | Fatigue | 48% |
13 | Dactylitis | 48% |
14 | Physician global | 41% |
15 | Tissue histology | 38% |
16 | Magnetic resonance imaging | 34% |
17 | Morning stiffness | 25% |
18 | Damaged joint count | 20% |